Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

The Bitter, Expensive Pill at the End of Life.

De Hert M, Distelmans W.

JAMA Oncol. 2017 Nov 1;3(11):1587-1588. doi: 10.1001/jamaoncol.2017.1650. No abstract available.

PMID:
28817748
2.

Euthanasia requests, procedures and outcomes for 100 Belgian patients suffering from psychiatric disorders: a retrospective, descriptive study.

Thienpont L, Verhofstadt M, Van Loon T, Distelmans W, Audenaert K, De Deyn PP.

BMJ Open. 2015 Jul 27;5(7):e007454. doi: 10.1136/bmjopen-2014-007454.

4.

Nationwide survey to evaluate the decision-making process in euthanasia requests in Belgium: do specifically trained 2nd physicians improve quality of consultation?

Cohen J, Van Wesemael Y, Smets T, Bilsen J, Onwuteaka-Philipsen B, Distelmans W, Deliens L.

BMC Health Serv Res. 2014 Jul 16;14:307. doi: 10.1186/1472-6963-14-307.

5.

The prevalence of burnout among oncology professionals: oncologists are at risk of developing burnout.

Eelen S, Bauwens S, Baillon C, Distelmans W, Jacobs E, Verzelen A.

Psychooncology. 2014 Dec;23(12):1415-22. doi: 10.1002/pon.3579. Epub 2014 May 21.

PMID:
24846818
6.

Requests for euthanasia/physician-assisted suicide on the basis of mental suffering: vulnerable patients or vulnerable physicians?

Deschepper R, Distelmans W, Bilsen J.

JAMA Psychiatry. 2014 Jun;71(6):617-8. doi: 10.1001/jamapsychiatry.2014.185. No abstract available.

PMID:
24759890
7.

Systematic screening for distress in oncology practice using the Distress Barometer: the impact on referrals to psychosocial care.

Bauwens S, Baillon C, Distelmans W, Theuns P.

Psychooncology. 2014 Jul;23(7):804-11. doi: 10.1002/pon.3484. Epub 2014 Jan 24.

PMID:
24458691
8.

Palliative sedation: why we should be more concerned about the risks that patients experience an uncomfortable death.

Deschepper R, Laureys S, Hachimi-Idrissi S, Poelaert J, Distelmans W, Bilsen J.

Pain. 2013 Sep;154(9):1505-8. doi: 10.1016/j.pain.2013.04.038. Epub 2013 Apr 26. Review. No abstract available.

9.

Implementation of a service for physicians' consultation and information in euthanasia requests in Belgium.

Van Wesemael Y, Cohen J, Bilsen J, Smets T, Onwuteaka-Philipsen B, Distelmans W, Deliens L.

Health Policy. 2012 Mar;104(3):272-8. doi: 10.1016/j.healthpol.2011.12.001. Epub 2012 Jan 5.

PMID:
22226142
10.

Consulting a trained physician when considering a request for euthanasia: an evaluation of the process in flanders and the Netherlands.

Van Wesemael Y, Cohen J, Bilsen J, Onwuteaka-Philipsen BD, Distelmans W, Deliens L.

Eval Health Prof. 2010 Dec;33(4):497-513. doi: 10.1177/0163278710370605. Epub 2010 May 18.

PMID:
20484059
11.

Role and involvement of life end information forum physicians in euthanasia and other end-of-life care decisions in Flanders, Belgium.

Van Wesemael Y, Cohen J, Onwuteaka-Philipsen BD, Bilsen J, Distelmans W, Deliens L.

Health Serv Res. 2009 Dec;44(6):2180-92. doi: 10.1111/j.1475-6773.2009.01042.x. Epub 2009 Sep 24.

12.

Characteristics of referral to a multidisciplinary palliative home care team.

Drieskens K, Bilsen J, Van Den Block L, Deschepper R, Bauwens S, Distelmans W, Deliens L.

J Palliat Care. 2008 Autumn;24(3):162-6.

PMID:
18942566
13.

The 'Distress Barometer': validation of method of combining the Distress Thermometer with a rated complaint scale.

Bauwens S, Baillon C, Distelmans W, Theuns P.

Psychooncology. 2009 May;18(5):534-42. doi: 10.1002/pon.1425.

PMID:
18823077
14.

Development of palliative care and legalisation of euthanasia: antagonism or synergy?

Bernheim JL, Deschepper R, Distelmans W, Mullie A, Bilsen J, Deliens L.

BMJ. 2008 Apr 19;336(7649):864-7. doi: 10.1136/bmj.39497.397257.AD. No abstract available.

15.

Attitudes and knowledge about cancer pain in Flanders. The educational effect of workshops regarding pain and symptom control.

Bauwens S, Distelmans W, Storme G, Kaufman L.

Palliat Med. 2001 May;15(3):181-9.

PMID:
11407189
16.
17.

Phase I trial of erbulozole (R55104).

Van Belle SJ, Distelmans W, Vandebroek J, Bruynseels J, Van Ginckel R, Storme GA.

Anticancer Res. 1993 Nov-Dec;13(6B):2389-91.

PMID:
8135472
18.

5'-Nor-anhydrovinblastine (Navelbine) has an anti-invasive effect on MO4 mouse fibrosarcoma cells in vitro and in vivo.

Van den Berge D, Bruyneel E, Distelmans W, Van Belle S, Krikonian A, Breillout F, Storme G.

Anticancer Res. 1993 Jan-Feb;13(1):273-7.

PMID:
8476224
19.

The effects of short-term treatment with levamisole on cytokines in volunteers and cancer-patients.

Debrabander M, Roels V, Vogels O, Demoen B, Deridder R, Jagers E, Baisier A, Doolaege R, Decoster R, Aerts F, Vandebroek J, Decree J, Verhaegen H, Dewaele M, Distelmans W, Vanbelle S, Storme G.

Int J Oncol. 1992 Aug;1(3):337-40.

PMID:
21584552
20.

Levamisole plus 5-fluorouracil inhibits the growth of human colorectal xenografts in nude mice.

Van Ginckel R, Distelmans W, De Brabander M, Callens M, Janssens B, Jagers E, Wouters L, De Coster R, Janssen PA.

Eur J Cancer. 1992;28A(6-7):1137-9.

PMID:
1627384
21.

Erbulozole (P.I.N.N.) (R 55 104) encapsulated into cyclodextrins: has it a combined antitumoral and radioprotective potential?

Distelmans W, Van Ginckel R, Vanherck W, Willebrords R, Wouters L, De Brabander M, Mesens J.

Anticancer Res. 1991 Jan-Feb;11(1):253-6.

PMID:
2018359
22.

Antitumoral effects of R 75251 on the growth of transplantable R3327 prostatic adenocarcinoma in rats.

Van Ginckel R, De Coster R, Wouters W, Vanherck W, van der Veer R, Goeminne N, Jagers E, Van Cauteren H, Wouters L, Distelmans W, et al.

Prostate. 1990;16(4):313-23.

PMID:
2371176
23.

Influence of the synthetic microtubule inhibitor erbulozole (P.I.N.N.) (R 55 104), a new tubulozole congener, and gamma irradiation on murine tumors in vivo.

Distelmans W, Van Ginckel R, Vanherck W, Willebrords R, De Brabander M, Wouters L, Heeres J.

Eur J Cancer Clin Oncol. 1989 Oct;25(10):1499-504.

PMID:
2591442
24.

Interaction between the microtubule inhibitor tubulozole and gamma-irradiation in murine tumors in vivo.

Distelmans W, Van Ginckel R, Vanherck W, Willebrords R, De Brabander M, Wouters L, Van den Winkel P, De Backer G.

Int J Radiat Oncol Biol Phys. 1989 Jan;16(1):177-82.

PMID:
2912940
25.

Numerical evaluation of the kidney invasion test.

Boghaert ER, Distelmans W, Van Ginckel R, Mareel MM.

Invasion Metastasis. 1987;7(4):230-41.

PMID:
3667145
26.

The kidney invasion test: its application to the Lewis lung carcinoma system.

Van Ginckel R, Vanherck W, Willebrords R, Distelmans W, De Brabander M.

Anticancer Res. 1986 Jul-Aug;6(4):705-8.

PMID:
3752948
27.

Tubulozole: a new stereoselective microtubule inhibitor.

De Brabander M, Geuens G, Nuydens R, Willebrords R, Moeremans M, Van Ginckel R, Distelmans W, Dragonetti C, Mareel M.

Ann N Y Acad Sci. 1986;466:757-66. No abstract available.

PMID:
3460448
28.

Influence of the salmon mutant of Glossina morsitans morsitans on the susceptibility to infection with Trypanosoma congolense.

Distelmans W, Makumyaviri AM, D'Haeseleer F, Claes Y, Le Ray D, Gooding RH.

Acta Trop. 1985 Jun;42(2):143-8.

PMID:
2862776
30.

Efficacy of systemic administration of ivermectin against tsetse flies.

Distelmans W, D'Haeseleer F, Mortelmans J.

Ann Soc Belg Med Trop. 1983 Jun;63(2):119-25. No abstract available.

PMID:
6688512
31.

The susceptibility of gamma-irradiated Glossina palpalis palpalis at different ages to infection with Trypanosoma congolense.

Distelmans W, D'Haeseleer F.

Ann Soc Belg Med Trop. 1983 Mar;63(1):21-8. No abstract available.

PMID:
6859970
32.

The susceptibility of Glossina palpalis palpalis at different ages to infection with Trypanosoma congolense.

Distelmans W, D'Haeseleer F, Kaufman L, Rousseeuw P.

Ann Soc Belg Med Trop. 1982 Mar;62(1):41-7. No abstract available.

PMID:
7103580

Supplemental Content

Loading ...
Support Center